TREATMENT OF RECALCITRANT RADIATION MACULOPATHY USING INTRAVITREAL DEXAMETHASONE (OZURDEX) IMPLANT

Abstract

Ozurdex intravitreal implant provides a prolonged period of anatomical stabilization in recalcitrant cases of radiation maculopathy in patients who have failed multiple intravitreal bevacizumab injections and had only a partial response to intravitreal triamcinolone. Larger prospective studies are required to determine the extent of visual benefit.